These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6168075)

  • 1. Isolation of immunogenic and suppressogenic determinants of the nonimmunogenic YAC tumor and the change in its immunogenic repertoire after in vitro cultivation.
    Klein BY; Devens B; Deutsch O; Ahituv A; Frenkel S; Kobrin BJ; Naor D
    Transplant Proc; 1981 Mar; 13(1 Pt 2):790-7. PubMed ID: 6168075
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of antitumor reactive cells or suppressor cells by different molecular species isolated from the same nonimmunogenic tumor.
    Klein BY; Sharon R; Tarcic N; Naor D
    Immunobiology; 1982 Oct; 163(1):7-21. PubMed ID: 6217150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and partial characterization of a tumor-associated antigen of the P815 mastocytoma of DBA/2 mice.
    Al-Rammahy AK; Levy JG; Jackson AL
    J Immunol; 1980 Jan; 124(1):143-50. PubMed ID: 6765966
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune responses to weakly immunogenic virally induced tumors. V. Short in vitro cultivation of YAC changes its antigenic properties.
    Devens B; Schochot L; Naor D
    Cell Immunol; 1979 May; 44(2):442-53. PubMed ID: 88269
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration and characterization of polyoma-tumor-associated antigenic components using preparative and analytical polyacrylamide gel electrophoresis.
    Porwit-Bóbr Z; Pawełek J; Górka M
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):11-6. PubMed ID: 6184028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
    Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
    Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation of immunogenic and suppressogenic glycoproteins from adenovirus type 12 hamster tumor cells.
    Yamamoto H
    Microbiol Immunol; 1984; 28(3):339-48. PubMed ID: 6330504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of meth A cell surface membranes possessing tumor-specific transplantation antigen activity.
    McCollester DL
    Cancer Res; 1970 Dec; 30(12):2832-7. PubMed ID: 5494569
    [No Abstract]   [Full Text] [Related]  

  • 10. Separation of the specific antigen of a mouse lymphoma from histocompatibility antigens.
    Davies DA; Baugh VS; Buckham S; Manstone AJ
    Eur J Cancer (1965); 1974 Dec; 10(12):781-6. PubMed ID: 4471650
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice.
    Sun T; Kim TS; Waltz MR; Cohen EP
    Cancer Gene Ther; 1995 Sep; 2(3):183-90. PubMed ID: 8528961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of low molecular protein P-9 from nuclei of NK/Ly lymphoma and Guerin carcinoma.
    Kazmin SD; Danko IM; Kolosov EV; Pinchuk VG
    Neoplasma; 1983; 30(5):521-5. PubMed ID: 6656956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dependence of concomitant tumor immunity on continued antigenic stimulation.
    Gershon RK; Kondo K
    J Natl Cancer Inst; 1971 Jun; 46(6):1169-75. PubMed ID: 5088042
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunogenic and tumorigenic properties of a murine lymphoma that expresses foreign alloantigens: role of helper factor(s) in generating a cytotoxic response in vitro.
    Scott JW; Finke JH
    Transplant Proc; 1981 Dec; 13(4):1867-73. PubMed ID: 6800082
    [No Abstract]   [Full Text] [Related]  

  • 15. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of a murine B lymphoma tumor-specific antigen.
    Koch S; Zalcberg JR; McKenzie IF
    J Immunol; 1984 Aug; 133(2):1070-7. PubMed ID: 6203965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
    Wiltrout RH; Frost P
    J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
    [No Abstract]   [Full Text] [Related]  

  • 18. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
    Gjedde SB
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of merozoite rhoptries, identification of novel rhoptry-associated proteins from Plasmodium yoelii, P. chabaudi, P. berghei, and conserved interspecies reactivity of organelles and proteins with P. falciparum rhoptry-specific antibodies.
    Sam-Yellowe TY; Del Rio RA; Fujioka H; Aikawa M; Yang JC; Yakubu Z
    Exp Parasitol; 1998 Jul; 89(3):271-84. PubMed ID: 9676705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical aspects of the study of neoplastic antigens].
    Lisiewicz J; Moszczyński P
    Pol Tyg Lek; 1984 Feb; 39(6):201-4. PubMed ID: 6204325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.